Prognostic implication of leucocyte subpopulations in diffuse large B-cell lymphoma

Xiao Han; Jing Ruan; Wei Zhang; Daobin Zhou; Dongsheng Xu; Qiang Pei; Mingqi Ouyang; Mengxuan Zuo

doi:10.18632/oncotarget.17830

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Prognostic implication of leucocyte subpopulations in diffuse large B-cell lymphoma

Xiao Han, Jing Ruan, Wei Zhang _, Daobin Zhou, Dongsheng Xu, Qiang Pei, Mingqi Ouyang and Mengxuan Zuo

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2017; 8:47790-47800. https://doi.org/10.18632/oncotarget.17830

Metrics: PDF 1902 views | HTML 2365 views | ?

Abstract

Xiao Han1,*, Jing Ruan1,*, Wei Zhang1, Daobin Zhou1, Dongsheng Xu2, Qiang Pei1, Mingqi Ouyang1 and Mengxuan Zuo1

1Department of Hematology, Peking Union Medical College Hospital, Beijing, China 100730

2Department of Hematopathology, CBLPath, Sonic Healthcare, Rye Brook, NY 10573, USA

*These authors have contributed equally to this work

Correspondence to:

Wei Zhang, email: [email protected]

Keywords: diffuse large B-cell lymphoma, prognosis, CD16- monocyte/CD16+ monocyte ratio, mature neutrophil/cytotoxic NK&T cell ratio, CytoDiff flow cytometric system

Received: November 02, 2016 Accepted: March 08, 2017 Published: May 12, 2017

ABSTRACT

Background: Recent studies have suggested that variables related to host adaptive immunity and the tumor microenvironment may predict the outcome in patients with non-Hodgkin’s lymphoma. This study was undertaken to determine the prognostic value of peripheral blood leucocyte subpopulations in diffuse large-B-cell lymphoma patients.

Methods: We prospectively analyzed the 16 leukocyte subpopulations using Cytodiff flow cytometric technique in a cohort of 45 diffuse large-B-cell lymphoma patients at a single institution between February and December 2014. The Cox proportional hazards model was used to evaluate prognostic factors for overall survival and progression free survival.

Results: Diffuse large-B-cell lymphoma patients had decreased cytotoxic and non-cytotoxic NK&T cells as well as increased CD16+ monocytes, CD16- monocytes and mature neutrophils. The decreased CD16- monocyte/CD16+ monocyte ratio and increased mature neutrophil/cytotoxic NK&T cell ratio were related to poor progression-free and overall survival outcome in single and multivariate analysis. The co-constructed model using International Prognostic Index and mature neutrophil/cytotoxic NK&T cell ratio can also help discriminate the clinical outcome.

Conclusions: The decreased CD16-monocyte/CD16+monocyte ratio and increased mature neutrophil/cytotoxic NK&T cell ratio predict poor prognosis in diffuse large-B-cell lymphoma patients. This finding provides a strong rationale for the study of cellular immunotherapy in B-cell lymphoma.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 17830

Publication Alerts

Research Papers:

Prognostic implication of leucocyte subpopulations in diffuse large B-cell lymphoma

Abstract